Published online before print June 3, 2004, doi: 10.1161/01.ATV.0000134530.27208.41
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 American Heart Association, Inc.
Brief Reviews |
Lysosomal Cysteine Proteases in Atherosclerosis
From the Department of Molecular and Cell Biology (J.L., J.-S.S., W.-H.X.), School of Life Science, University of Science and Technology of China, Hefei, Anhui, China; and Donald W. Reynolds Cardiovascular Clinical Research Center (G.K.S., P.L., G.-P.S.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Guo-Ping Shi, DSc, Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, 77 Ave Louis Pasteur, NRB-7, Boston, MA 02115. E-mail gshi{at}rics.bwh.harvard.edu
Atherosclerosis is an inflammatory disease characterized by extensive remodeling of the extracellular matrix architecture of the arterial wall. Although matrix metalloproteinases and serine proteases participate in these pathologic events, recent data from atherosclerotic patients and animals suggest the participation of lysosomal cysteine proteases in atherogenesis. Atherosclerotic lesions in humans overexpress the elastolytic and collagenolytic cathepsins S, K, and L but show relatively reduced expression of cystatin C, their endogenous inhibitor, suggesting a shift in the balance between cysteine proteases and their inhibitor that favors remodeling of the vascular wall. Extracts of human atheromatous tissue show greater elastolytic activity in vitro than do those from healthy donors. The cysteinyl protease inhibitor E64d limits this increased elastolysis, indicating involvement of cysteine proteases in elastin degradation during atherogenesis. Furthermore, inflammatory cytokines augment expression and secretion of active cysteine proteases from cultured monocyte-derived macrophages, vascular smooth muscle cells, and endothelial cells and increase degradation of extracellular elastin and collagen. Cathepsin S–deficient cells or those treated with E64d show significantly impaired elastolytic or collagenolytic activity. Additionally, recent in vivo studies of atherosclerosis-prone, LDL receptor–null mice lacking cathepsin S show participation of this enzyme in the initial infiltration of leukocytes, medial elastic lamina degradation, endothelial cell invasion, and neovascularization, illustrating an important role for cysteine proteases in arterial remodeling and atherogenesis.
Atherosclerosis is an inflammatory disease characterized by extensive remodeling of the extracellular matrix architecture of the arterial wall. Although matrix metalloproteinases and serine proteases participate in these pathologic events, recent data from atherosclerotic patients and animals suggest the participation of lysosomal cysteine proteases in atherogenesis.
Key Words: atherosclerosis • cysteine proteases • cathepsins • cystatin • cytokines
This article has been cited by other articles:
 |
|
 |
|
  J.-F. Cailhier, I. Sirois, P. Laplante, S. Lepage, M.-A. Raymond, N. Brassard, A. Prat, R. V. Iozzo, A. V. Pshezhetsky, and M.-J. Hebert Caspase-3 Activation Triggers Extracellular Cathepsin L Release and Endorepellin Proteolysis J. Biol. Chem., October 3, 2008; 283(40): 27220 - 27229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Eggers, L. Lind, H. Ahlstrom, T. Bjerner, C. Ebeling Barbier, A. Larsson, P. Venge, and B. Lindahl Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects Eur. Heart J., September 2, 2008; 29(18): 2252 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Burden, P. Snoddy, R. J. Buick, J. A. Johnston, B. Walker, and C. J. Scott Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment Mol. Cancer Ther., March 1, 2008; 7(3): 538 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Wieslander, S. I. Marinis, P. G. Drewes, P. W. Keller, J. F. Acevedo, and R. A. Word Regulation of Elastolytic Proteases in the Mouse Vagina During Pregnancy, Parturition, and Puerperium Biol Reprod, March 1, 2008; 78(3): 521 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ni, J. Lu, L. Bo Hou, J. Tao Yan, Q. Fan, R. Hui, K. Cianflone, W. Wang, and D. Wen Wang Cystatin C, Associated With Hemorrhagic and Ischemic Stroke, Is a Strong Predictor of the Risk of Cardiovascular Events and Death in Chinese Stroke, December 1, 2007; 38(12): 3287 - 3288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Welch, Y. Sun, B. J. Arey, V. Lemaitre, N. Sharma, M. Ishibashi, S. Sayers, R. Li, A. Gorelik, N. Pleskac, et al. Spontaneous Atherothrombosis and Medial Degradation in Apoe / , Npc1 / Mice Circulation, November 20, 2007; 116(21): 2444 - 2452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O. McDonald, R. G. Gerrity, C. Jen, H.-J. Chen, K. Wark, T. N. Wight, A. Chait, and K. D. O'Brien Diabetes and Arterial Extracellular Matrix Changes in a Porcine Model of Atherosclerosis J. Histochem. Cytochem., November 1, 2007; 55(11): 1149 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kotsyfakis, S. Karim, J. F. Andersen, T. N. Mather, and J. M. C. Ribeiro Selective Cysteine Protease Inhibition Contributes to Blood-feeding Success of the Tick Ixodes scapularis J. Biol. Chem., October 5, 2007; 282(40): 29256 - 29263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. M. Lutgens, K. B. J. M. Cleutjens, M. J. A. P. Daemen, and S. Heeneman Cathepsin cysteine proteases in cardiovascular disease FASEB J, October 1, 2007; 21(12): 3029 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2379 - 2393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Jaffer, D.-E. Kim, L. Quinti, C.-H. Tung, E. Aikawa, A. N. Pande, R. H. Kohler, G.-P. Shi, P. Libby, and R. Weissleder Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor Circulation, May 1, 2007; 115(17): 2292 - 2298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kitamoto, G. K. Sukhova, J. Sun, M. Yang, P. Libby, V. Love, P. Duramad, C. Sun, Y. Zhang, X. Yang, et al. Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice Circulation, April 17, 2007; 115(15): 2065 - 2075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Mitchell and P. Libby Vascular Remodeling in Transplant Vasculopathy Circ. Res., April 13, 2007; 100(7): 967 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Abdul-Hussien, R. G.V. Soekhoe, E. Weber, J. H. von der Thusen, R. Kleemann, A. Mulder, J. H. van Bockel, R. Hanemaaijer, and J. H.N. Lindeman Collagen Degradation in the Abdominal Aneurysm: A Conspiracy of Matrix Metalloproteinase and Cysteine Collagenases Am. J. Pathol., March 1, 2007; 170(3): 809 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Libby Perplexity of Plaque Proteinases Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2181 - 2182. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taleb, R. Cancello, K. Clement, and D. Lacasa Cathepsin S Promotes Human Preadipocyte Differentiation: Possible Involvement of Fibronectin Degradation Endocrinology, October 1, 2006; 147(10): 4950 - 4959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pryshchep, K. Sato, J. J. Goronzy, and C. M. Weyand T Cell Recognition and Killing of Vascular Smooth Muscle Cells in Acute Coronary Syndrome Circ. Res., May 12, 2006; 98(9): 1168 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taleb, R. Cancello, C. Poitou, C. Rouault, P. Sellam, P. Levy, J.-L. Bouillot, C. Coussieu, A. Basdevant, M. Guerre-Millo, et al. Weight Loss Reduces Adipose Tissue Cathepsin S and Its Circulating Levels in Morbidly Obese Women J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1042 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Suganuma, Y. Zuo, N. Ayabe, J. Ma, V. R. Babaev, M. F. Linton, S. Fazio, I. Ichikawa, A. B. Fogo, and V. Kon Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction J. Am. Soc. Nephrol., February 1, 2006; 17(2): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-P. Shi and G. M. Dolganov Comprehensive Transcriptome of Proteases and Protease Inhibitors in Vascular Cells Stroke, February 1, 2006; 37(2): 537 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lutgens, S.P.M. Lutgens, B.C.G. Faber, S. Heeneman, M.M.J. Gijbels, M.P.J. de Winther, P. Frederik, I. van der Made, A. Daugherty, A.M. Sijbers, et al. Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation Circulation, January 3, 2006; 113(1): 98 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bengtsson, F. To, K. Hakansson, A. Grubb, L. Branen, J. Nilsson, and S. Jovinge Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2151 - 2156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lee, F. Forudi, G. M. Saidel, and M. S. Penn Alterations in Internal Elastic Lamina Permeability As a Function of Age and Anatomical Site Precede Lesion Development in Apolipoprotein E-Null Mice Circ. Res., September 2, 2005; 97(5): 450 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Diaz-Perales, V. Quesada, J. R. Peinado, A. P. Ugalde, J. Alvarez, M. F. Suarez, F. X. Gomis-Ruth, and C. Lopez-Otin Identification and Characterization of Human Archaemetzincin-1 and -2, Two Novel Members of a Family of Metalloproteases Widely Distributed in Archaea J. Biol. Chem., August 26, 2005; 280(34): 30367 - 30375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Srivastava, S. Jung, J. Wilhelm, L. Fink, F. Buhling, T. Welte, R. M. Bohle, W. Seeger, J. Lohmeyer, and U. A. Maus The Inflammatory versus Constitutive Trafficking of Mononuclear Phagocytes into the Alveolar Space of Mice Is Associated with Drastic Changes in Their Gene Expression Profiles J. Immunol., August 1, 2005; 175(3): 1884 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hansson Inflammation, Atherosclerosis, and Coronary Artery Disease N. Engl. J. Med., April 21, 2005; 352(16): 1685 - 1695. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Levin Cystatin C, Serum Creatinine, and Estimates of Kidney Function: Searching for Better Measures of Kidney Function and Cardiovascular Risk Ann Intern Med, April 5, 2005; 142(7): 586 - 588. [Full Text] [PDF]
|
|
|
|
|
|
T. N. Wight The ADAMTS Proteases, Extracellular Matrix, and Vascular Disease: Waking the Sleeping Giant(s)! Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 12 - 14. [Full Text] [PDF]
|
|